Back to search
FDAFDA · Food and drugs·Recall number D-0596-2025

Acetaminophen Injection 1000 mg/100 mL (10 mg/mL), packaged in 100 mL Viaflo container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in Ireland, NDC 36000-306-60.

Published September 3, 2025 · Recall initiated: August 20, 2025

Summary

FDA records drug Class II recall D-0596-2025, published September 3, 2025 and initiated August 20, 2025. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 13,000 containers; Lot: Lot #: 24A27G66, Exp 12/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration

What to do

Voluntary: Firm initiated · Letter

Get an email if ACETAMINOPHEN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ACETAMINOPHEN
Manufacturer
Baxter Healthcare Corporation
Distributor
U.S.A. Nationwide
Lot
Lot #: 24A27G66, Exp 12/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Acetaminophen Injection 1000 mg/100 mL (10 mg/mL), packaged in 100 mL Viaflo container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in Ireland, NDC 36000-306-60. recalled?

Yes. FDA published recall D-0596-2025 on September 3, 2025. Reported hazard: Discoloration

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ACETAMINOPHEN.